Marin Kollef

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi Ventilator-associated complications, including infection-related complications: the way forward
    Marin H Kollef
    Washington University School of Medicine, St Louis, MO 63110, USA
    Crit Care Clin 29:33-50. 2013
  2. ncbi Economic impact of ventilator-associated pneumonia in a large matched cohort
    Marin H Kollef
    Washington University School of Medicine, St Louis, MO 63110, USA
    Infect Control Hosp Epidemiol 33:250-6. 2012
  3. ncbi Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials
    Lutz E Lehmann
    Department of Anesthesiology and Pain Therapy, University Hospital Bern, Inselspital, Freiburgstrasse, CH 3010 Bern, Switzerland
    Crit Care 14:R186. 2010
  4. ncbi CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study
    Kevin L Lawrence
    Department of Medicine, Washington University in St, Louis School of Medicine, 660 South Euclid, Campus Box 8052, St Louis, Missouri 63110, USA
    Crit Care 14:R110. 2010
  5. ncbi Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit
    Lee P Skrupky
    Department of Pharmacy, Barnes Jewish Hospital, St Louis, MO 63110, USA
    Crit Care 13:222. 2009
  6. ncbi Candidemia on presentation to the hospital: development and validation of a risk score
    Andrew F Shorr
    Pulmonary and Critical Care Medicine Service, Washington Hospital Center, Washington, DC 20010, USA
    Crit Care 13:R156. 2009
  7. ncbi Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study
    Marya D Zilberberg
    EviMed Research Group, LLC, PO Box 303, Goshen, MA 01032, USA
    BMC Infect Dis 10:150. 2010
  8. ncbi Healthcare-associated pneumonia: approach to management
    Andrew Labelle
    Division of Pulmonary and Critical Care, Washington University School of Medicine, St Louis, MO 63110, USA
    Clin Chest Med 32:507-15. 2011
  9. ncbi Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study
    Marin H Kollef
    Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    J Infect 62:130-5. 2011
  10. ncbi Prevention of ventilator-associated pneumonia or ventilator-associated complications: a worthy, yet challenging, goal
    Marin H Kollef
    Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
    Crit Care Med 40:271-7. 2012

Collaborators

Detail Information

Publications29

  1. ncbi Ventilator-associated complications, including infection-related complications: the way forward
    Marin H Kollef
    Washington University School of Medicine, St Louis, MO 63110, USA
    Crit Care Clin 29:33-50. 2013
    ..The use of evidence-based bundles targeting the reduction of VACs, as well as the conduct of prospective studies showing that VACs are preventable complications, are reasonable first-steps in addressing this important clinical problem...
  2. ncbi Economic impact of ventilator-associated pneumonia in a large matched cohort
    Marin H Kollef
    Washington University School of Medicine, St Louis, MO 63110, USA
    Infect Control Hosp Epidemiol 33:250-6. 2012
    ..To evaluate the economic impact of ventilator-associated pneumonia (VAP) on length of stay and hospital costs. Design. Retrospective matched cohort study...
  3. ncbi Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials
    Lutz E Lehmann
    Department of Anesthesiology and Pain Therapy, University Hospital Bern, Inselspital, Freiburgstrasse, CH 3010 Bern, Switzerland
    Crit Care 14:R186. 2010
    ..We analyze the impact on medical outcomes and healthcare costs if improved adequacy of antimicrobial therapy is achieved by providing immediate coverage after positive PCR reports...
  4. ncbi CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study
    Kevin L Lawrence
    Department of Medicine, Washington University in St, Louis School of Medicine, 660 South Euclid, Campus Box 8052, St Louis, Missouri 63110, USA
    Crit Care 14:R110. 2010
    ..Our objective was to describe a cohort of patients with sepsis in terms of their measured immune status...
  5. ncbi Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit
    Lee P Skrupky
    Department of Pharmacy, Barnes Jewish Hospital, St Louis, MO 63110, USA
    Crit Care 13:222. 2009
    ..Although vancomycin has long been considered a first-line therapy for serious MRSA infections, multiple concerns with this agent have opened the door for existing and investigational agents demonstrating efficacy in this role...
  6. ncbi Candidemia on presentation to the hospital: development and validation of a risk score
    Andrew F Shorr
    Pulmonary and Critical Care Medicine Service, Washington Hospital Center, Washington, DC 20010, USA
    Crit Care 13:R156. 2009
    ..Candidemia results in substantial morbidity and mortality, especially if initial antifungal therapy is delayed or is inappropriate; however, candidemia is difficult to diagnose because of its nonspecific presentation...
  7. ncbi Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study
    Marya D Zilberberg
    EviMed Research Group, LLC, PO Box 303, Goshen, MA 01032, USA
    BMC Infect Dis 10:150. 2010
    ..Inappropriate antifungal therapy (IAT) is known to increase a patient's risk for death. We hypothesized that in an ICU cohort it would also adversely affect resource utilization...
  8. ncbi Healthcare-associated pneumonia: approach to management
    Andrew Labelle
    Division of Pulmonary and Critical Care, Washington University School of Medicine, St Louis, MO 63110, USA
    Clin Chest Med 32:507-15. 2011
    ..Ability to predict infection with MDR organisms varies, and the relative frequency of MDR organisms varies by geographic region. Initial treatment is broad-spectrum empiric antibiotics...
  9. ncbi Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study
    Marin H Kollef
    Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    J Infect 62:130-5. 2011
    ..Regarding bloodstream infection (BSI), little data exist differentiating healthcare-associated bacteremia (HCAB) from community-acquired bacteremia (CAB). We studied the epidemiology and outcomes associated with HCAB...
  10. ncbi Prevention of ventilator-associated pneumonia or ventilator-associated complications: a worthy, yet challenging, goal
    Marin H Kollef
    Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
    Crit Care Med 40:271-7. 2012
    ..The use of evidence-based bundles targeting ventilator-associated pneumonia seems to be a reasonable first step in addressing this important clinical problem...
  11. ncbi Prevention of nosocomial pneumonia in the intensive care unit: beyond the use of bundles
    Marin H Kollef
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63021, USA
    Surg Infect (Larchmt) 12:211-20. 2011
    ....
  12. ncbi Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators
    Marin H Kollef
    Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA
    Crit Care 14:R84. 2010
    ....
  13. ncbi Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit
    Marin H Kollef
    Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, 660 South Euclid Ave, Campus Box 8052, St Louis, MO 63110, USA
    Clin Infect Dis 53:S33-55; quiz S56-8. 2011
    ..The results then were compared with the same survey completed by 138 infectious disease and critical care physicians and are the basis of this article...
  14. ncbi Using protocols to improve patient outcomes in the intensive care unit: focus on mechanical ventilation and sepsis
    Marin H Kollef
    Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Semin Respir Crit Care Med 31:19-30. 2010
    ..This review focuses on the use of protocols in the ICU setting and how they can best be utilized to improve patient outcomes...
  15. ncbi Severe hospital-acquired pneumonia: a review for clinicians
    John Dallas
    Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, Campus Box 8052, 660 South Euclid Avenue, St Louis, MO 63110, USA
    Curr Infect Dis Rep 11:349-56. 2009
    ..A large body of scientific literature about HAP now exists. This article summarizes the current state of knowledge concerning severe HAP with an emphasis on recent advances in its diagnosis, treatment, and prevention...
  16. ncbi The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*
    Andrew Labelle
    Division of Pulmonary and Critical Care, Washington University School of Medicine, St Louis, MO, USA
    Crit Care Med 40:2016-21. 2012
    ..To identify the determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment...
  17. ncbi Risk factors for acute adverse events during ultrasound-guided central venous cannulation in the emergency department
    Daniel Theodoro
    Washington University School of Medicine, St Louis, MO, USA
    Acad Emerg Med 17:1055-61. 2010
    ..Despite the ability to visualize the needle and anatomy, adverse events still occur. The authors hypothesized that the technique has limitations among certain patients and clinical scenarios...
  18. ncbi Clostridium difficile in the ICU: the struggle continues
    Linda D Bobo
    Adult Infectious Diseases Division, University School of Medicine, St Louis, MO, USA
    Chest 140:1643-53. 2011
    ....
  19. ncbi Effect of kinetic therapy on pulmonary complications
    Thomas Ahrens
    Barnes-Jewish Hospital, St. Louis, MO, USA
    Am J Crit Care 13:376-83. 2004
    ..CONCLUSION: Kinetic therapy helps prevent ventilator-associated pneumonia and lobar atelectasis in critically ill patients. Costs to rent the bed may be offset by the potential cost reduction associated with kinetic therapy...
  20. ncbi Toward a two-tier clinical warning system for hospitalized patients
    Gregory Hackmann
    Department of Computer Science and Engineering, Washington University, St Louis, MO, USA
    AMIA Annu Symp Proc 2011:511-9. 2011
    ..Preliminary study of an early warning system component and a wireless clinical monitoring system component demonstrate the feasibility of this two-tiered approach...
  21. ncbi A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?
    Laura A Puzniak
    Department of Community Health, Saint Louis University School of Public Health, St Louis, Missouri, USA
    Infect Control Hosp Epidemiol 25:418-24. 2004
    ..To determine the net benefit and costs associated with gown use in preventing transmission of vancomycin-resistant Enterococcus (VRE)...
  22. ncbi Septic shock attributed to Candida infection: importance of empiric therapy and source control
    Marin Kollef
    Pulmonary and Critical Care Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Clin Infect Dis 54:1739-46. 2012
    ..However, septic shock attributed to Candida infection and its determinants of outcome have not been previously evaluated in a large patient population...
  23. ncbi A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia
    Marin Kollef
    Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8052, St Louis, MO 63110, USA
    Am J Respir Crit Care Med 173:91-7. 2006
    ..The drug has shown little resistance in vitro and to be safe and well tolerated in 800 patients with cancer treated for up to 6 wk...
  24. ncbi A descriptive comparison of ultrasound-guided central venous cannulation of the internal jugular vein to landmark-based subclavian vein cannulation
    Daniel Theodoro
    Division of Emergency Medicine, Washington University School of Medicine, St Louis, MO, USA
    Acad Emerg Med 17:416-22. 2010
    ..The purpose of this study was to describe adverse event rates among operators using the USIJ approach, and the landmark SC vein approach without US...
  25. ncbi SMART approaches for reducing nosocomial infections in the ICU
    Marin Kollef
    Washington University School of Medicine, MO 63110, USA
    Chest 134:447-56. 2008
    ..Make objectives time bound; set dates for collecting baseline and periodic data, and a completion date for evaluating the success of the intervention...
  26. ncbi Use of hypochlorite solution to decrease rates of Clostridium difficile-associated diarrhea
    Kathleen M McMullen
    Barnes Jewish Hospital, St Louis, MO 63108, USA
    Infect Control Hosp Epidemiol 28:205-7. 2007
    ..One unit instituted enhanced environmental cleaning with a hypochlorite solution in all rooms, whereas the other unit used hypochlorite solution only in rooms of patients with CDAD. The CDAD rates decreased in both units...
  27. ncbi Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time
    Marin Kollef
    Pulmonary and Critical Care Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Drugs 63:2157-68. 2003
    ..Antibacterial resistance is minimised by narrowing the antibacterial regimen once the pathogens and their susceptibility profiles are determined, and by employing the shortest course of therapy clinically acceptable...
  28. ncbi Improving family communications at the end of life: implications for length of stay in the intensive care unit and resource use
    Tom Ahrens
    Barnes-Jewish Hospital, St. Louis, MO, USA
    Am J Crit Care 12:317-23; discussion 324. 2003
    ..CONCLUSIONS: Use of a physician and a clinical nurse specialist focused on improving communication with patients and patients' families reduced lengths of stay and resource utilization...
  29. ncbi Ventilator-associated tracheobronchitis in a mixed surgical and medical ICU population
    John Dallas
    Department of Pulmonary and Critical Care Medicine, Washington University School of Medicine, and Department of Pharmacy, Barnes Jewish Hospital, 660 S Euclid Ave, Campus Box 8052, St Louis, MO 63110, USA
    Chest 139:513-8. 2011
    ..The purpose of this prospective cohort study was to further characterize VAT in terms of incidence, etiology, and impact on patient outcomes...